Fludarabine monophosphate as salvage for refractory chronic lymphocytic leukaemia

South African Medical Journal

Volumn 86, Issue 8, 1996, Pages 949-951

  Pillay, G S ^a   Wood, Lucille ^a   Jacobs, Peter ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; FLUDARABINE PHOSPHATE;

ARTICLE; BONE MARROW SUPPRESSION; CELL COUNT; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MULTIMODALITY CANCER THERAPY; NEUTROPHIL; PNEUMOCYSTIS PNEUMONIA; REMISSION; WHOLE BODY RADIATION;

ANTIMETABOLITES, ANTINEOPLASTIC; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; MALE; REMISSION INDUCTION; SALVAGE THERAPY; SOUTH AFRICA; VIDARABINE PHOSPHATE;

EID: 0029851783     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Rai KR, Sawitzky A, Cronkite EP, Chanana AD, Levy RN, Pasternak BS. Clinical staging of chronic lymphocyte leukemia. Blood 1975; 46: 219-234.
2. Binet JL, Auquier A, Dighiero G, et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 1981; 48: 198-206.
3. Montserrat E, Rozman C. Chronic lymphocytic leukaemia treatment. Blood Rev 1993; 7: 164-175.
4. Cheson BD, Bennett JM, Rai KR, et al. Guidelines for clinical protocols for chronic lymphocytic leukemia (CLL): recommendations of the NCl-Sponsored Working Group. Am J Hematol 1986; 29: 152-163.
5. Knospe WH, Loeb V, Huhuley CM. Bi-weekly chlorambucil treatment of chronic lymphocytic leukemia. Cancer 1974; 33: 555-562.
6. Sawitzky A, Rai KR, Glidewell O, et al. Comparison of daily versus intermittent chlorambucil and prednisone therapy in the treatment of patients with chronic lymphocytic leukemia. Blood 1977; 50: 1049-1059.
7. Liepman M, Votaw ML. The treatment of chronic lymphocytic leukemia with COP chemotherapy. Cancer 1978; 41: 1664-1669.
8. Kempin S, Lee BJ, Thaler HT, et al. Combination chemotherapy of advanced chronic lymphocytic leukemia: the M-2 protocol (vincristine, BCNU, cyclophosphamide, melphalan, and prednisone). Blood 1982; 60: 1110-1121.
9. Keating MJ, Scouros M, Murphy S, et al. Multiple agent chemotherapy (POACH) in previously treated and untreated patients with chronic lymphocytic leukemia. Leukemia 1988; 2: 157-164.
10. Jacobs P, King HS. A randomized prospective comparison of chemotherapy to total body irradiation as initial treatment for the indolent lymphoproliferative diseases. Blood 1987; 69: 1642-1646.
11. Grever MR, Kopecky KJ, Coltman CA, et al. Fludarabine monophosphate: a potentially useful agent in chronic lymphocytic leukemia. Nouv Rev Fr Hematol 1988; 30: 457-459.
12. Keating MJ, Kantarjian H, Talpaz M, et al. Fludarabine: a new agent with major activity against chronic lymphocyte leukemia. Blood 1989; 74: 19-25.
13. Ross S, McTavish D, Faulds D. Fludarabine: a review of its pharmacological properties and therapeutic potential in malignancy. Drugs 1993; 45: 737-759.
14. Keating MJ, Kantarjian H, O'Brien S, et al. Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia. J Clin Oncol 1991; 9: 44-49.
15. Johnson C, King H, Wood L, Fullard L, Paulsen W, Jacobs P. Cyclophosphamide and sequential hemi-body radiotherapy in managing patients with chronic lymphocytic leukaemia (Abstract). Fourth Congress of the South African Lymphoma Study Group, Cape Town, 3-5 Sep 1990.
16. International Workshop on Chronic Lymphocytic Leukemia. Chronic lymphocytic leukemia: recommendations for diagnosis, staging, and response criteria. Ann Intern Med 1989; 110: 236-238.
17. Keating MJ, O'Brien S, Kantarjian H, et al. Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent. Blood 1993; 81: 2878-2884.
18. Johnson SA, Richardson D, Hopkins J, Howe D, Phillips MJ. Complete remission after fludarabine for chronic lymphocytic leukemia. Blood 1993; 81: 560-566.
19. Piro LD, Carrera CJ, Beutler E, Carson DA. 2-Chlorodeoxyadenosine: an effective new agent for the treatment of chronic lymphocytic leukemia. Blood 1988; 72: 1069-1073.
20. Dillman RO, Mick R, McIntyre OR. Pentostatin in chronic lymphocytic leukemia: a phase II trial of Cancer and Leukemia Group B. Clin Oncol 1989; 7: 433-438.
21. Bastion Y, Coiffier B, Tigaud B, Espinouse JD, Bryon PA. Pneumocystis pneumonia in a patient treated with fludarabine for chronic lymphocytic leukaemia. Eur J Cancer 1992; 27: 671.
22. Schilling PJ, Vadhan-Raj S. Concurrent cytomegalovirus and pneumocystis pneumonia after fludarabine therapy for chronic lymphocytic leukemia. N Engl J Med 1990; 323: 833-834.
23. Leporrier M, Reman O, Troussard X. Pure red-cell aplasia with fludarabine for chronic lymphocytic leukaemia. Lancet 1993; 342: 555.
24. Warrell RP, Berman E. Phase I and II study of fludarabine phosphate in leukemia: therapeutic efficacy with delayed central nervous system toxicity. J Clin Oncol 1986; 4: 74-79.
25. Spriggs DR, Stopa E, Mayer RJ, Schoene W, Kufe DW. Fludarabine monophosphate (NSC 312878) infusions for the treatment of acute leukemia: phase I and neuropathological study. Cancer Res 1986; 46: 5953-5958.
26. Cohen RB, Abdallah JM, Gray JR, Foss F. Reversible neurologic toxicity in patients treated with standard-dose fludarabine phosphate for mycosis fungoides and chronic lymphocytic leukemia. Ann Intern Med 1993; 118: 114-116.
27. O'Brien S, Kantarjian H, Beran M, et al. Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment. Blood 1993; 82: 1695-1700.
28. Kemena A, Gandhi V, Shewach DS, Keating M, Plunkett W. Inhibition of fludarabine metabolism by arabinosylcytosine during therapy. Cancer Chemother Pharmacol 1992; 31: 193-199.
29. Delannoy A, Hanique G, Ferrant A. 2-Chlorodeoxyadenosine for patients with B-cell chronic lymphocytic leukemia resistant to fludarabine. N Engl J Med 1993; 328: 812.